Avalo Therapeutics (AVTX) Receivables - Other (2016 - 2024)
Historic Receivables - Other for Avalo Therapeutics (AVTX) over the last 9 years, with Q4 2024 value amounting to -$600000.0.
- Avalo Therapeutics' Receivables - Other fell 54117.65% to -$600000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$600000.0, marking a year-over-year decrease of 54117.65%. This contributed to the annual value of -$600000.0 for FY2024, which is 54117.65% down from last year.
- According to the latest figures from Q4 2024, Avalo Therapeutics' Receivables - Other is -$600000.0, which was down 54117.65% from $998000.0 recorded in Q3 2024.
- In the past 5 years, Avalo Therapeutics' Receivables - Other registered a high of $4.3 million during Q3 2020, and its lowest value of -$600000.0 during Q4 2024.
- In the last 5 years, Avalo Therapeutics' Receivables - Other had a median value of $1.4 million in 2022 and averaged $1.4 million.
- In the last 5 years, Avalo Therapeutics' Receivables - Other surged by 195826.64% in 2020 and then crashed by 54117.65% in 2024.
- Quarter analysis of 5 years shows Avalo Therapeutics' Receivables - Other stood at $2.2 million in 2020, then surged by 69.34% to $3.7 million in 2021, then plummeted by 48.68% to $1.9 million in 2022, then plummeted by 92.91% to $136000.0 in 2023, then tumbled by 541.18% to -$600000.0 in 2024.
- Its Receivables - Other stands at -$600000.0 for Q4 2024, versus $998000.0 for Q3 2024 and $33000.0 for Q2 2024.